Comparison of early quality of life outcomes in autologous and allogeneic transplant patients

Bone Marrow Transplantation
C M GarciaP J Stiff

Abstract

The Functional Assessment of Cancer Therapy-Bone Marrow Transplant measures quality of life (QOL) in SCT patients. Prior reports found mixed results regarding QOL differences among autologous and allogeneic SCT patients. In addition, there is a paucity of literature examining differences in QOL patterns over time between autologous and allogeneic patients. The present study examines differences in QOL between patients free of clinical depression undergoing autologous (n = 41) and allogeneic (n = 64) SCT during early stages of treatment. Despite clinical differences, autologous and allogeneic patients demonstrated similar changes in QOL. The exception was the Functional subscale which indicated worse QOL for allogeneic patients at discharge (F test = 4.61, df = 1, P < 0.05); allogeneic patients (Mean = 13.06, s.d. = 5.36) indicated they were less able to function at work and were less accepting of their illness than autologous patients (Mean = 16.02, s.d. = 6.73). There was a significant main effect for time on nearly all QOL subscales (P < 0.05) demonstrating decline during treatment and return to baseline by discharge; only the Social Well-Being scale did not significantly change over time. These results help to understand pat...Continue Reading

References

Jun 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·D F CellaP Bonomi
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
Dec 1, 1996·Journal of Personality Assessment·A T BeckW Ranieri
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J BradyG Shiomoto
Jun 25, 2002·Bone Marrow Transplantation·P C TraskJ Ferrara
May 20, 2004·JAMA : the Journal of the American Medical Association·Karen L SyrjalaPaul J Martin
Jan 22, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A AndrykowskiJohn R Wingard
Apr 9, 2005·Cancer Nursing·Katherine L ByarSuzanne L Nuss
Jan 24, 2007·Journal of the National Comprehensive Cancer Network : JNCCN·Paul B Jacobsen, Sean Ransom
Jun 11, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nicole M RankinAlison Evans
Aug 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mahmut Ozsahin, Hulya Ozsahin
Sep 9, 2010·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Rebecca J BeekenChristopher Dalley
Jan 26, 2011·Journal of Consulting and Clinical Psychology·Christine RiniKatherine N Duhamel

❮ Previous
Next ❯

Citations

Jun 30, 2016·Revista brasileira de enfermagem·Vanessa da RochaLuciana Puchalski Kalinke
Nov 1, 2018·Revista latino-americana de enfermagem·Angela da Costa Barcellos MarquesLuciana Puchalski Kalinke
Apr 11, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sam H AhmedzaiUNKNOWN National Cancer Research Institute Haemato-Oncology Clinical Studies Group
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Ashley RoskoAngela Dispenzieri
Sep 14, 2017·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Aleksandra KroemekeZuzanna Kwissa-Gajewska
Jan 5, 2021·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Giana Berleze PennaBruna Ziegler
Jul 29, 2021·World Journal of Transplantation·Henrietta JanicsákGábor Gazdag

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.